Northern Trust’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.9M Sell
929,500
-62,696
-6% -$2.32M ﹤0.01% 1434
2025
Q4
$41.8M Sell
992,196
-82,186
-8% -$3.31M 0.01% 1222
2025
Q3
$36.9M Buy
1,074,382
+103,921
+11% +$2.98M ﹤0.01% 1316
2025
Q2
$26.2M Sell
970,461
-74,070
-7% -$2.15M ﹤0.01% 1483
2025
Q1
$31M Sell
1,044,531
-24,656
-2% -$940K ﹤0.01% 1365
2024
Q4
$42.3M Buy
1,069,187
+120,752
+13% +$4.57M 0.01% 1224
2024
Q3
$32.3M Buy
948,435
+17,525
+2% +$493K 0.01% 1317
2024
Q2
$20.2M Sell
930,910
-35,572
-4% -$748K ﹤0.01% 1557
2024
Q1
$21.4M Sell
966,482
-13,315
-1% -$325K ﹤0.01% 1549
2023
Q4
$27M Sell
979,797
-2,531
-0.3% -$61.1K ﹤0.01% 1405
2023
Q3
$21.9M Buy
982,328
+270,531
+38% +$6.96M ﹤0.01% 1481
2023
Q2
$18.1M Buy
711,797
+27,980
+4% +$678K ﹤0.01% 1662
2023
Q1
$15.2M Sell
683,817
-9,392
-1% -$227K ﹤0.01% 1733
2022
Q4
$16.4M Sell
693,209
-113,909
-14% -$2.65M ﹤0.01% 1665
2022
Q3
$13.4M Sell
807,118
-9,700
-1% -$218K ﹤0.01% 1772
2022
Q2
$16.3M Sell
816,818
-63,387
-7% -$1.28M ﹤0.01% 1681
2022
Q1
$24.3M Buy
880,205
+6,312
+0.7% +$181K ﹤0.01% 1537
2021
Q4
$36M Buy
873,893
+4,110
+0.5% +$182K 0.01% 1354
2021
Q3
$40.4M Sell
869,783
-15,342
-2% -$669K 0.01% 1249
2021
Q2
$35.4M Sell
885,125
-57,478
-6% -$2.46M 0.01% 1437
2021
Q1
$50.7M Buy
942,603
+71,100
+8% +$4.1M 0.01% 1119
2020
Q4
$42.7M Buy
871,503
+1,058
+0.1% +$49K 0.01% 1201
2020
Q3
$28.3M Buy
870,445
+65,094
+8% +$2.07M 0.01% 1346
2020
Q2
$20.9M Buy
805,351
+60,398
+8% +$1.5M ﹤0.01% 1588
2020
Q1
$18.1M Buy
744,953
+137,155
+23% +$3.45M 0.01% 1476
2019
Q4
$17M Sell
607,798
-12,108
-2% -$313K ﹤0.01% 1851
2019
Q3
$14.9M Buy
619,906
+220,869
+55% +$5.88M ﹤0.01% 1888
2019
Q2
$11.4M Buy
399,037
+53,792
+16% +$1.34M ﹤0.01% 2069
2019
Q1
$8.64M Sell
345,245
-643
-0.2% -$12.3K ﹤0.01% 2243
2018
Q4
$4.35M Sell
345,888
-5,654
-2% -$66.9K ﹤0.01% 2586
2018
Q3
$3.36M Buy
351,542
+82,176
+31% +$906K ﹤0.01% 2924
2018
Q2
$2.52M Sell
269,366
-1,692
-0.6% -$11.9K ﹤0.01% 3088
2018
Q1
$1.51M Sell
271,058
-216
-0.1% -$1.34K ﹤0.01% 3244
2017
Q4
$1.77M Sell
271,274
-3,020
-1% -$22.5K ﹤0.01% 3206
2017
Q3
$2.41M Buy
274,294
+293
+0.1% +$2.38K ﹤0.01% 3061
2017
Q2
$2.28M Buy
274,001
+78,574
+40% +$641K ﹤0.01% 3099
2017
Q1
$1.79M Buy
195,427
+11,447
+6% +$93.7K ﹤0.01% 3137
2016
Q4
$1.43M Buy
183,980
+7,021
+4% +$52.5K ﹤0.01% 3244
2016
Q3
$1.35M Buy
176,959
+24,749
+16% +$140K ﹤0.01% 3253
2016
Q2
$765K Buy
152,210
+14,587
+11% +$78.2K ﹤0.01% 3417
2016
Q1
$743K Buy
137,623
+178
+0.1% +$1.05K ﹤0.01% 3348
2015
Q4
$990K Buy
137,445
+307
+0.2% +$2.07K ﹤0.01% 3332
2015
Q3
$643K Buy
137,138
+60,492
+79% +$576K ﹤0.01% 3440
2015
Q2
$854K Buy
76,646
+6,710
+10% +$66.1K ﹤0.01% 3402
2015
Q1
$509K Hold
69,936
﹤0.01% 3600
2014
Q4
$676K Sell
69,936
-1,244
-2% -$9.71K ﹤0.01% 3476
2014
Q3
$694K Buy
71,180
+6,696
+10% +$87.9K ﹤0.01% 3500
2014
Q2
$1.1M Buy
64,484
+2,125
+3% +$30.6K ﹤0.01% 3362
2014
Q1
$1.07M Sell
62,359
-4,211
-6% -$67.3K ﹤0.01% 3379
2013
Q4
$965K Buy
+66,570
New +$866K ﹤0.01% 3387

Other funds holding VCYT

Northern Trust's VCYT Position: Q1 2026 in Review

Northern Trust reduced its Veracyte (VCYT) stake by 6.3% in Q1 2026, selling an estimated $2.32M and leaving 929,500 shares worth $29.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1434.

Northern Trust first reported a position in VCYT in Q4 2013 and has held it in 50 quarters since. The position peaked at $50.7M in Q1 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Northern Trust held 929,500 shares of Veracyte worth $29.9M as of Q1 2026.
  • Northern Trust sold 62,696 Veracyte shares in Q1 2026, an estimated $2.32M.
  • Veracyte made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1434 holding.
  • Northern Trust first reported a position in Veracyte in Q4 2013 and has held it in 50 quarters since.
  • Northern Trust's Veracyte position peaked at $50.7M in Q1 2021.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.